Where does Myriad Genetics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Myriad Genetics, Inc. ranks #10,695 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Myriad Genetics, Inc. hold?

Myriad Genetics, Inc. holds 29 US utility patents granted between 2015 and 2025, spanning 11 technology areas.

What is Myriad Genetics, Inc.'s Innovation Score?

Myriad Genetics, Inc. has an Innovation Score of 32.1 out of 100 (40th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Myriad Genetics, Inc.'s patent grant rate increasing or decreasing?

Myriad Genetics, Inc.'s recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Myriad Genetics, Inc.'s patents?

Myriad Genetics, Inc.'s patents average 11.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Myriad Genetics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Myriad Genetics, Inc.

Q: What technology areas does Myriad Genetics, Inc. focus on?

Myriad Genetics, Inc.'s top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 25 patents, ranking #182 of 2,502 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

USPTO PatentsView assignee record - 29 granted patents across 11 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Myriad ranks #10,695 of 49,997 tracked US assignees by granted-patent volume, with 29 patents across 11 technology areas.

#10,695
of 49,997 US assignees by volume: 40th percentile
by Innovation Score (32.1/100): 11.8
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10695 · US Corporation #10,695 · 29 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 29 grants
UPPER-Q #10,695/49,997
PHOTO-FINISH Moderna Therapeutics
CPC-FOCUS C12Q · 11 areas
INNOV-THIN 32.1/100
CLAIMS-PAR 11.8 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Moderna Therapeutics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Myriad’s 32.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.7 pts (37%) Velocity 1.5 pts (5%) Breadth 11.7 pts (37%) Claim depth 7.1 pts (22%)

Qualcomm Incorporated · highest

85
Automotive Research… · near

32
Ergomotion · near

32
Myriad Genetics · this assignee

32
Siga · near

32
Xiamen R&T Plumbing… · near

32
3D Lighting… · lowest

7

What this shows Myriad's Innovation Score is 32.1/100 (40th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Myriad?

Each dot is one of Myriad’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Myriad’s own 11.8 claims/patent is at or below the 13.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Myriad vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Myriad's grants concentrate

Myriad Genetics, Inc. is a focused PatentsView assignee: 11 CPC subclasses with 86.2% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2016 (5 grants) versus a trough of 1 in 2015. By volume, Myriad sits between Moderna Therapeutics, Inc. and NEC Lighting, Ltd..

Myriad's three-year grant acceleration

Myriad Genetics, Inc. shows 3 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Moderna Therapeut…

29
Moraine

29
Moshun

29
Movellus Circuits

29
Myriad Women's He…

29
Nanoport Technolo…

29
National Agricult…

29
NEC Lighting

29
Myriad Genetics ◀

29

What this shows Myriad holds 29 patents at rank #10,694, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Myriad

By rank, the assignees closest to #10,694 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Myriad's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Myriad, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), Myriad ranks #182 of 2,502 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (32 here).

Siga Technologies, Inc. 32 Ergomotion, Inc. 32 Automotive Research & Test Center 32 Xiamen R&T Plumbing Technology Co., Ltd. 32

Myriad's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 40th percentile higher than 40% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Myriad Genetics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	3.4%
2016	5	17.2%
2017	3	10.3%
2018	1	3.4%
2019	3	10.3%
2020	5	17.2%
2021	5	17.2%
2022	3	10.3%
2025partial year	3	10.3%

Which technologies does Myriad Genetics, Inc. patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 25

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 18

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 11

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 4

G06F - Electric Digital Data Processing 2

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

C07K - Peptides 1

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 1

G06V - Image OR Video Recognition OR Understanding 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Myriad Genetics, Inc.'s patent record in context - here's where to go next.

Myriad Genetics, Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 86.2% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #10,695 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Myriad Genetics, Inc. against Moderna Therapeutics, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 32.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.